» Articles » PMID: 9120489

The Incidence of Guillain-Barre Syndrome in Ferrara, Italy: is the Disease Really Increasing?

Overview
Journal J Neurol Sci
Publisher Elsevier
Specialty Neurology
Date 1996 Apr 1
PMID 9120489
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

The Guillain-Barre syndrome (GBS) incidence has been updated in the area of the Local Health District of Ferrara, Unita Sanitaria Locale n. 31 (USL 31), Northern Italy, (where a previous survey found an average annual incidence of 1.26/10000 population) in order to verify a supposed increase in GBS occurrence. The updated mean annual incidence over the years from 1981 to 1993 (average resident population: 177235 inhabitants) was 1.87/100000 population (1.66/100000 when age-adjusted). The rate increased progressively in the four subsequent time intervals into which the study period was subdivided (from 1.09/100000 in the years 1981-1984 to 2.73/100000 in the years 1991-1993) with a significant temporal variation (0.025 <p <0.05). The incidence was higher in the urban centres than in the rural zone of USL 31 (2.22/100000 and 1.10/100000; 0.025 <p <0.05) and an increase of GBS risk in the urban area was found. The incidence showed an increase in the oldest age groups of the study population. These findings seem to confirm a slight increase of GBS risk in the area of Ferrara with particular reference to urban centres and elderly people.

Citing Articles

Axonal variants of Guillain-Barré syndrome: an update.

Shang P, Zhu M, Wang Y, Zheng X, Wu X, Zhu J J Neurol. 2020; 268(7):2402-2419.

PMID: 32140865 DOI: 10.1007/s00415-020-09742-2.


Guillain-Barré syndrome in Denmark: validation of diagnostic codes and a population-based nationwide study of the incidence in a 30-year period.

Levison L, Thomsen R, Christensen D, Mellemkjaer T, Sindrup S, Andersen H Clin Epidemiol. 2019; 11:275-283.

PMID: 31114387 PMC: 6497480. DOI: 10.2147/CLEP.S199839.


Incidence study of Guillain-Barré syndrome in the province of Ferrara, Northern Italy, between 2003 and 2017. A 40-year follow-up.

Granieri E, Andreasi N, De Martin P, Govoni V, Castellazzi M, Cesnik E Neurol Sci. 2019; 40(3):603-609.

PMID: 30617450 DOI: 10.1007/s10072-018-3688-4.


More severe manifestations and poorer short-term prognosis of ganglioside-associated Guillain-Barré syndrome in Northeast China.

Wu X, Wu W, Wang Z, Shen D, Pan W, Wang Y PLoS One. 2014; 9(8):e104074.

PMID: 25084153 PMC: 4118971. DOI: 10.1371/journal.pone.0104074.


Guillain-Barré syndrome.

Seneviratne U Postgrad Med J. 2000; 76(902):774-82.

PMID: 11085768 PMC: 1741839. DOI: 10.1136/pmj.76.902.774.